| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.768 | 8.555 | 19.856 | 39.345 | 35.863 |
| Total Income - EUR | - | - | - | - | - | 3.970 | 10.562 | 19.863 | 43.126 | 42.879 |
| Total Expenses - EUR | - | - | - | - | - | 3.245 | 6.943 | 15.006 | 42.380 | 30.617 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 725 | 3.619 | 4.857 | 746 | 12.263 |
| Net Profit/Loss - EUR | - | - | - | - | - | 645 | 3.362 | 4.693 | 398 | 11.919 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 2 | 1 |
Check the financial reports for the company - Genes Total Mc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 63 | 3.620 | 3.293 | 3.283 | 5.777 |
| Current Assets | - | - | - | - | - | 1.510 | 8.478 | 20.078 | 36.484 | 59.122 |
| Inventories | - | - | - | - | - | 1.489 | 6.381 | 16.034 | 25.521 | 28.122 |
| Receivables | - | - | - | - | - | 0 | 241 | 53 | 7.127 | 5.581 |
| Cash | - | - | - | - | - | 21 | 1.856 | 3.991 | 3.836 | 25.419 |
| Shareholders Funds | - | - | - | - | - | 687 | 4.033 | 10.051 | 10.419 | 22.280 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 0 | 0 |
| Debts | - | - | - | - | - | 886 | 8.064 | 13.320 | 29.348 | 42.619 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1623 - 1623" | |||||||||
| CAEN Financial Year |
1623
|
|||||||||
Comments - Genes Total Mc S.r.l.